Christopher B Ehrlich
CIK 1293973 · Chairman and CEO · last filed 2026-01-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
37
Lifetime Open-Market Net
$8.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Chairman and CEO | 5,795,408 | $0.05 | $290.3K | $0 | 8 | 2026-01-09 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | 177,381 | $0.00 | $106 | $90.7K | 13 | 2024-06-13 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | CEO and Secretary | 699,996 | $10.37 | $7.26M | $0 | 1 | 2021-10-12 |
| LWACU | See Remarks | — | $10.30 | — | $0 | 1 | 2021-01-14 |
| BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted | Director | 6,846 | — | — | $8.00M | 5 | 2009-04-08 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +346 | $197 | EDGAR |
| 2022-09-27 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +18,867 | $10.4K | EDGAR |
| 2022-06-13 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-22 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +3,000 | $13.2K | EDGAR |
| 2022-02-10 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +2,000 | $9.7K | EDGAR |
| 2022-02-07 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +6,000 | $30.8K | EDGAR |
| 2022-01-31 | eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Buy (P) | +5,000 | $26.5K | EDGAR |
| 2021-10-12 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Other (J) | +36,733 | $367.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.